CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

22 hedge funds and large institutions have $16.1M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.45M
2
$1.27M
3
$895K
4
$693K
5
$613K
6
$597K
7
$596K
8
$371K
9
$367K
10
$319K
11
$241K
12
$238K
13
$182K
14
$118K
15
$56K
16
$50K
17
$29K
18
$20K
19
$11K
20
$4K
21
22